MYOS RENS Technology Inc (NASDAQ:MYOS)
MYOS RENS Technology Inc (NASDAQ:MYOS) stock is up almost 20% with two hours remaining in the trading day. Shares benefitted from the announcement of a partnership with the owner of Fortetropin® in support of the NFL Alumni NY/NJ Chapter’s Optimal Bowl and Wellness Challenge.
MYOS – NFL Alumni Partnership
The 90-day Wellness challenge will feature former NFL players and military veterans working together with world class medical specialists in a variety of activities designed to improve their individual health. Throughout the wellness challenge, the public will be able to follow challenge participants’ journeys to wellness through reality-based web TV documentary series and mass media initiatives that will include preventive health information and educate the public about wellness. This educational competition culminates with the showdown of health and wellness, the Optimal Bowl.
Joseph Mannello, Chief Executive Officer of MYOS RENS Technology Inc (NASDAQ:MYOS) stated “We are happy to be supporting the NFL Alumni in the Optimal Bowl and Wellness Challenge, to raise awareness about the importance of muscle health. It’s a proven fact that we start losing lean muscle with each decade of life, beginning at 30 years of age. Our partnership with the NFL Alumni fits perfectly within our mission of promoting the benefits of Fortetropin® in a regular exercise regimen, regardless of age or physical condition,”
MYOS RENS Technology Inc (NASDAQ:MYOS) is up over 25% year-to-date and up over 11% in just the last week. However, the stock is relatively flat over the past year as MYOS shares had spiked early in 2017 and remained above $3.50 for much of January and February. Since then, shares have been sliding.
Sales have been a shadow of what they used to be. In 2013 and 2014 sales were posted at $3.3 million each year. However the company reported sales of $200,000 for 2015 and $300,000 for 2016.
I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.
Don’t miss out! Stay informed on $MYOS and receive breaking news on other hot stocks by signing up for our free newsletter!
About the author: James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.